Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Perhaps A Question for Letter?

Re: "Strategic Partnership"? pautaotzu

posted on Apr 26, 2008 05:20PM

There are commericalization guidelines set forth in the master agreement that should protect PTSC.

Note the bold highlight, but also read b) after highlight

ARTICLE II
COMMERCIALIZATION


2.1 TPL shall exert reasonable best efforts to implement the
activities (the "Commercialization") described at Schedule 2 and to conduct the
project described therein ("Project") in accordance with the project description
(the "Project Description") including the Business Plan then in effect.

(a) The first Business Plan is made a part of the Project Description
as Attachment I to Schedule 2, and shall remain in full force and effect until
replaced by agreement of P-Newco and TPL.

(b) TPL shall have no obligation to pursue or fund any effort to
prosecute, maintain, enforce or defend any element of the MSD Patents other than
as specifically provided for in Schedule 2.

2.2 By these presents, P-Newco appoints, authorizes, and directs TPL
to take any and all action for the term of this Commercialization Agreement,
with respect to all matters that are related to P-Newco's rights to the MSD
Patents, including without limitation:

(a) entering into settlement and/or license agreements related to the
MSD Patents which meet the Commercialization guidelines set forth in Section II
of Schedule 2
;

(b) with the prior written consent of the P-Newco Management
Committee, entering into any settlement and license agreements related to the
MSD Patents which do not meet the guidelines set forth in Section II of Schedule
2;

(c) to sue in the name of TPL, Moore, Patriot and/or P-Newco and to
pursue for the use and benefit of the parties hereto as their respective
interests appear: (i) all remedies of whatsoever kind or nature with respect to
the protection, use, and enforcement of the MSD Patents; (ii) the collection of
all claims for damages, profits, and awards relating to the past, present, or
future use or ownership of the MSD Patents; and (iii) all equitable relief
available in connection therewith; and

(d) to otherwise manage and control by license, sublicense, or other
agreement the practice and/or use of the MSD Patents by third parties.

2.3. TPL may utilize the services of its various licensing personnel
who may be lawyers to implement the Commercialization of the MSD Patents. Such
services shall for no purpose be deemed to be legal services or to give rise to
a lawyer-client relationship between TPL and/or TPL affiliates or
Representatives on the one hand, and P-Newco and/or Patriot or any of their
respective affiliates or Representatives on the other hand. Without limiting the
foregoing, neither TPL nor any TPL Representative shall for any purpose be
deemed to have:

(i) Provided legal services or advice to;

(ii) Undertaken the representation of; or

2

Share
New Message
Please login to post a reply